Schizophrenia Clinical Trial
Official title:
Mindfulness as a Rehabilitation Strategy in Schizophrenia
The purpose of this study is to develop a treatment manual for mindfulness meditation to be taught in a group format to individuals with schizophrenia who are engaged in vocational rehabilitation. This study will also determine whether mindfulness meditation is beneficial in terms of improving work function by reducing distressing emotional states and thinking patterns.
Objectives: Schizophrenia involves numerous difficulties including being aware of ones' own
thoughts and tolerating painful affects. As a result, persons with schizophrenia find coping
with life stressors quite challenging and thus have difficulty engaging successfully in
psychosocial activities such as work in spite of state of the art programs. To address this
problem this study will evaluate an intervention that has come to the fore that targets
these impairments called mindfulness. Mindfulness involves teaching individuals skills that
improve their ability to attend to their experience in the present moment while suspending
judgment and to purposefully shift their attention. Thus mindfulness enhances the ability to
monitor and manage emotions and thought processes so that individuals can reflect on,
choose, and implement more effective responses. Use of mindfulness skills with other
populations has led to more sustained behavior change than occurs with standard treatments.
Recently research has begun to indicate mindfulness interventions can be delivered with
success for individuals with schizophrenia. This pilot study will be a first step in
adapting mindfulness as a cognitive intervention for individuals with schizophrenia who are
engaging in vocational rehabilitation in order to maintain their functional gains beyond the
end of the program. Key questions to be answered through this study include: (1) Can a
mindfulness manual be developed that helps persons with schizophrenia enrolled in vocational
rehabilitation exhibit better work function and reduced levels of distressing emotional
states and thinking patterns?; (2) Can materials necessary for the faithful transmission of
the mindfulness group intervention/manual (MGI) in the current study be created?; (3) Can
mindfulness skills be adapted and successfully taught to and accepted by persons with
schizophrenia in a group setting?: (4) Will individuals with schizophrenia who practice
mindfulness benefit?; (5) What are the effect sizes with a reasonable control to study the
effectiveness of the manualized MGI? Research Design: This study will take place over 3
years and is divided into two phases: manual development and pilot study. In the manual
development phase existing mindfulness protocols will be adapted to target work function of
persons with schizophrenia. The randomized controlled pilot study phase will explore the
effects of the intervention on key outcome measures.
Methodology: A total of 52 individuals with schizophrenia or schizoaffective disorder will
be recruited from the Roudebush VA Medical Center (18 in the non-randomized, non-controlled
manual development phase 1 and 34 in the randomized controlled pilot phase 2). In phase one,
manual development, 18 participants will be recruited and following informed consent,
screened for eligibility using the SCID and anxiety measures. Once enrolled, three
successive groups of 6 participants will attend an 8-week mindfulness program consisting of
two 60-minute group training and practice sessions each week. The mindfulness program will
incorporate didactic and experiential elements aimed at learning mindfulness skills and
establishing a daily mindfulness practice. Based on the experience gained working with each
of these three initial cohorts, a mindfulness manual will be created. In phase two, the
pilot of the mindfulness manual, 34 additional participants will be recruited and randomized
to the mindfulness intervention or support group control. All groups will complete
assessments at baseline, monthly, at program end and 6 months after program end as well as
formative and summative program evaluations.
Clinical Significance: Results of this study will yield materials necessary to begin the
process of assembling a body of research validating scientifically the therapeutic value of
mindfulness for veterans with schizophrenia who are enrolled in vocational rehabilitation.
Findings may ultimately provide the VA system with information regarding a potentially cost
effective approach to the care of these veterans who are disabled by a chronic mental
illness that would be exportable to other VA vocational rehabilitation programs that have
patients with schizophrenia.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |